In this matter, TGFBR2 [79] has recently been proposed as a tumor suppressor with prognostic value in early-stage NSCLC; however, there is no prior evidence of an association between KLF13 and lung cancer prognosis, so further research is required. This evidence concerns the gene TGFBR2 and lung carcinoma.